Augmented membrane type 1 matrix metalloproteinase (MT1-MMP):MMP-2 messenger RNA ratio in gastric carcinomas with poor prognosis

Clinical Cancer Research

Volumn 4, Issue 9, 1998, Pages 2179-2186

  Caenazzo, Cristina ^a   Onisto, Maurizio ^a   Sartor, Luigi ^a   Scalerta, Romano ^a   Giraldo, Anna ^b   Nitti, Donato ^a   Garbisa, Spiridione ^a,c  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c Istituto di Istologia ed Embriologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; ENZYME PRECURSOR; GELATINASE A; MATRIX METALLOPROTEINASE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE; UROKINASE;

ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE MARKER; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH BIOPSY; STOMACH CARCINOMA;

BIOPSY; FEMALE; GELATINASES; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; PROGNOSIS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; URINARY PLASMINOGEN ACTIVATOR;

EID: 0031716627     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Liotta, L. A., and Stetler-Stevenson, W. G. Metalloproteinases and cancer invasion. Semin. Cancer Biol., 1: 99-106, 1990.
2. Giannelli, G., Falk-Marzillier, J., Schiraldi, O., Stetler-Stevenson, W. G., and Quaranta, V. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science (Washington DC), 277: 225-228, 1997.
3. Liotta, L. A., Steeg, P. S., and Stetler-Stevenson, W. G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64: 327-336, 1991.
4. Stetler-Stevenson, W. G., Brown, P. D., Onisto, M., Levy, A. T., and Liotta, L. A. Tissue inhibitor of metalloproteinase-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J. Biol. Chem., 265: 13933-13938, 1990.
5. Grigioni, W. F., D'Errico, A., Fiorentino, M., Baccarini, P., Onisto, M., Caenazzo, C., Stetler-Stevenson, W. G., Garbisa, S., and Mancini, A. M. Gelatinase A (MMP-2) and its mRNA detected in both neoplastic and stromal cells of tumors with different invasive and metastatic properties. Diagn. Mol. Pathol., 3: 163-169, 1994.
6. Garbisa, S., Scagliotti, G., Masiero, L., Di Francesco, C., Caenazzo, C., Onisto, M., Micela, M., Stetler-Stevenson, W. G., and Liotta, L. A. Correlation of serum metalloproteinase levels with lung cancer metastasis and response to therapy. Cancer Res., 52: 4548-4549, 1992.
7. Leone, A., Correale, M., Dragone, D., Paradiso, A., De Lena, M., Stetler-Stevenson, W. G., Liotta, L. A., Masiero, L., and Garbisa, S. Gelatinase A/MMP-2 serum levels and neoplastic progression in breast cancer patients. Int. J. Oncol., 4: 551-554, 1994.
8. Endo, K., Maehara, Y., Baba, H., Yamamoto, M., Tomisaki, S., Watanabe, A., Kakeji, Y., and Sugimachi, K. Elevated levels of serum and plasma metalloproteinases in patients with gastric cancer. Anticancer Res., 17: 2253-2258, 1997.
9. Sier, C. F. M., Kubben, F. J. G. M., Ganesh, S., Heerding, M. M., Griffioen, G., Hanemaaijer, R., van Krieken, J. H. J. M., Lamers, C. B. H. W., and Verspaget, H. W. Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma. Br. J. Cancer, 74: 413-417, 1996.
10. Zucker, S., Lysik, R. M., Stetler-Stevenson, W. G., Birkedal-Hansen, H., Mann, W., and Furie, M. Type IV collagenase/gelatinase (MMP-2) is not increased in plasma of patients with cancer. Cancer Epidemiol. Biomark. Prev., 1: 475-479, 1992.
11. Brown, P. D., Bloxidge, R. E., Anderson, E., and Howell, A. Expression of activated gelatinase in human invasive breast carcinoma. Clin. Exp. Metastasis, 11: 183-189, 1993.
12. Onisto, M., Riccio, M. P., Scannapieco, P., Caenazzo, C., Griggio, L., Spina, M., Stetler-Stevenson, W. G., and Garbisa, S. MMP-2/ TIMP-2 imbalance in lymph-node-positive breast carcinomas, as measured by RT-PCR. Int. J. Cancer, 3: 621-626, 1995.
13. Sava, G., Capozzi, I., Bergamo, A., Gagliardi, R., Cocchietto, M., Masiero, L., Onisto, M., Alessio, E., Mestroni, G., and Garbisa, S. Down-regulation of tumor gelatinase/inhibitor balance and preservation of tumor endothelium by an antimetastatic ruthenium complex. Int. J. Cancer, 68: 60-66, 1996.
14. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., and Seiki, M. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature (Lond.), 370: 61-65, 1994.
15. Mazzieri, R., Masiero, L., Zanetta, L., Monea, S., Onisto, M., Garbisa, S., and Mignatti, P. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. EMBO J., 16: 101-104, 1997.
16. Haupt, L. M., Thompson, E. W., Griffiths, L. R., and Irving, M. G. IS-RT-PCR assay detection of MT-MMP in a human breast cancer cell line. Biochem. Mol. Biol. Int., 39: 553-561, 1996.
17. Sato, H., Okada, Y., and Seiki, M. Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion. Thromb. Haemostasis, 78: 497-500, 1997.
18. Duffy, M. J., Duggan, C., Maguire, T., Mulcahy, K., Elvin, P., McDermott, E., Fennelly, J. J., and O'Higgins, N. Urokinase plasminogen activator as a predictor of aggressive disease in breast cancer. Enzyme Protein, 49: 85-93, 1996.
19. Koumura, H., Sugiyama, Y., Kuneida, K., and Saji, S. Significance in gene expression of matrix metalloproteinase-9, urokinase-type plasminogen activator and tissue inhibitor of metalloproteinase for metastases of gastric and/or colorectal cancer. Jap. J. Cancer and Chemo., 2: 324-331, 1997.
20. Mignatti, P., and Rifkin, D. B. Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev., 73: 161-195, 1993.
21. Grigioni, W., D'Errico, A., Fortunato, C., Fiorentino, M., Mancini, A. M., Stetler-Stevenson, W. G., Sobel, M. E., Liotta, L. A., Onisto, M., and Garbisa, S. Prognosis of gastric carcinoma revealed by interactions between tumor cells and basement membrane. Mod. Pathol., 7: 220-225, 1994.
22. Garbisa, S., Onisto, M., Peron, A., Perissin, L., Rapozzi, V., Zorzet, S., and Giraldi, T. Suppression of metastatic potential and up-regulation of gelatinase and uPA in LLC by Dacarbazine or Razoxane. Int. J. Cancer, 72: 1056-1061, 1997.
23. Onisto, M., Garbisa, S., Caenazzo, C., Freda, M. P., Di Francesco, C., Nitti, D., Liotta, L. A., and Stetler-Stevenson, W. G. Reverse transcription-polymerase chain reaction phenotyping of metalloproteinases and inhibitors involved in tumor matrix invasion. Diagn. Mol. Pathol., 2: 74-80, 1993.
24. Cox, D. R., and Oakes, D. Analysis of Survival Data. London: Chapman and Hall, 1984.
25. Negro, A., Onisto, M., Pellati, D., and Garbisa, S. CNTF up-regulation of TIMP-2 in neuroblastoma cells. Mol. Brain Res., 48: 30-36, 1997.
26. Dingemans, A-M. C., Brakenhoff, R. H., Postmus, P. E., and Giaccone, G. Detection of cytokeratin-19 transcripts by reverse transcriptase-polymerase chain reaction in lung cancer cell lines and blood of lung cancer patients. Lab. Investig., 77: 213-220, 1997.
27. Mimori, K., Mori, M., Shiraishi, T., Fujie, T., Baba, K., Haraguki, M., Abe, R., Ueo, H., and Akiyoshi, T. Clinical significance of tissue inhibitor of metalloproteinase expression in gastric carcinoma. Br. J. Cancer, 76: 531-536, 1997.
28. Clifford, S. C., Thomas, D. J., Neal, D. E., and Lunec, J. Increased mdr-1 gene transcript level in high-grade carcinoma of the bladder determined by quantitative PCR-based assay. Br. J. Cancer, 69: 680-686, 1994.
29. Poulsom, R., Pignatelli, M., Stetler-Stevenson, W. G., Liotta, L. A., Wright, P. A., Jeffery, R. E., Longcroft, J. M., Rogers, L., and Stamp, G. W. H. Stromal expression of 72 kDa type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am. J. Pathol., 141: 389-395, 1992.
30. Ganesh, S., Sier, C. F., Heerding, M. M., Van Krieken, J. H., Griffioen, G., Welvaart, K., Van De Velde, C. J., Verheijen, J. H., Lamers, C. B., and Verspaget, H. W. Prognostic value of the plasminogen activation system in patients with gastric carcinoma. Cancer (Phila.), 77: 1035-1043, 1996.
31. Collier, I. E., Wilhelm, S. M., Eisen, A. Z., Marmer, D. L., Grant, G. A., Seltzer, J. L., Cronberger, A., He, C., Bauer, G. A., and Goldberg, G. I. H-ras oncogene-transformed human bronchiolar epithelial cells (TBE-1) secrete a single metalloproteinase capable of degrading basement membrane collagen. J. Biol. Chem., 263: 6579-6587, 1988.
32. Ercolani, L., Florence, B., Denaro, M., and Alexander, M. Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J. Biol. Chem., 263: 15335-15341, 1988.